Ki67 antigen and PCNA proliferation markers predict survival in anorectal malignant melanoma

Histopathology

Volumn 41, Issue 6, 2002, Pages 519-525

  Ben Izhak, Ofer ^a,b   Bar Chana, M ^c   Sussman, L ^a   Dobiner, V ^d   Sandbank, J ^e   Cagnano, M ^f   Cohen, H ^g   Sabo, E ^h  

^a RAMBAM MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c National Cancer Registry   (Israel)

^d HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^e ASSAF HAROFEH MEDICAL CENTER   (Israel)

^f BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^g WESTERN GALILEE HOSPITAL   (Israel)

^h Carmel Medical Centre   (Israel)

Author keywords

Anorectal melanoma; Ki67 antigen; Proliferating cell nuclear antigen; Proliferation markers

Indexed keywords

CYCLINE; KI 67 ANTIGEN;

ADULT; AGED; ANORECTAL MALIGNANT MELANOMA; ANUS TUMOR; ARTICLE; CANCER; CANCER INVASION; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; SURVIVAL RATE; TUMOR NECROSIS;

AGED; AGED, 80 AND OVER; CELL DIVISION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LIVER NEOPLASMS; MALE; MELANOMA; MIDDLE AGED; NECROSIS; PREDICTIVE VALUE OF TESTS; PROLIFERATING CELL NUCLEAR ANTIGEN; RECTAL NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0037709914     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.2002.01444.x     Document Type: Article

References (30)

1. Cooper PH, Mills SE, Allen MS Jr. Malignant melanoma of the anus. Report of 12 patients and analysis of 255 additional cases. Dis. Colon Rectum 1982: 25; 693-703.
2. Wanebo HJ, Woodruff JM, Farr GH, Quan SH. Anorectal melanoma. Cancer 1981: 47; 1891-1900.
3. Weinstock MA. Epidemiology and prognosis of anorectal melanoma. Gastroenterology 1993: 104; 174-178.
4. Goldman S, Glimelius B, Påhlman L. Anorectal malignant melanoma in Sweden. Report of 49 patients. Dis. Colon Rectum 1990: 33; 874-877.
5. Kantarovsky A, Kaufman Z, Zager M, Lew S, Dinbar A. Anorectal region malignant melanoma. J. Surg. Oncol. 1988: 38; 77-79.
6. Antoniuk PM, Tjandra JJ, Webb BW, Petras RE, Milsom JW, Fazio VW. Anorectal malignant melanoma has a poor prognosis. Int. J. Colorectal Dis. 1993: 8; 81-86.
7. Ben-Izhak O, Levy R, Weill S et al. Anorectal malignant melanoma: a clinicopathological study, including immunohistochemistry and DNA flow cytometry. Cancer 1997: 79; 18-25.
8. Linden MD, Torres FX, Kubus J, Zarbo RJ. Clinical application of morphological and immunocytochemical assessments of cell proliferation. Am. J. Clin. Pathol. 1992; 97 (Suppl. 1): S4-S13.
9. Cuevas E, Jones DB, Wright DH. Immunohistochemical detection of tumour growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues. J. Pathol. 1993: 169; 477-478.
10. Vogt T, Zipperer KH, Vogt A, Holzel D, Landthaler M, Stolz W. p53-protein and Ki-67-antigen expression are both reliable biomarkers of prognosis in thick stage I nodular melanomas of the skin. Histopathology 1997: 30; 57-63.
11. Niezabitowski A, Czajecki K, Rys J et al. Prognostic evaluation of cutaneous malignant melanoma: a clinicopathological and immunohistochemical study. J. Surg. Oncol. 1999: 70; 150-160.
12. Kelman Z. PCNA structure, functions and interactions. Oncogene 1997: 14; 629-640.
13. Sawhney N, Hall PA. Ki67 - structure, function, and new antibodies. J. Pathol. 1992: 168: 161-162.
14. Kelleher L, Magee HM, Dervan PA. Evaluation of cell-proliferation antibodies reactive in paraffin sections. Appl. Immunohistochem. 1994; 2; 164-170.
15. Linden MD, el-Naggar AK, Nathanson SD, Jacobson G, Zarbo RJ. Lack of correlation between flow cytometric and immunohistological proliferation measurements of tumors. Mod. Pathol. 1996; 9; 682-689.
16. Kirkegaard LJ, DeRose PB, Yao B, Cohen C. Image cytometric measurement of nuclear proliferation markers (MIB-1. PCNA) in astrocytomas. Prognostic significance. Am. J. Clin. Pathol. 1998; 109; 69-74.
17. Stone CH, Lynch EF, Linden MD, Kubus JJ, Zarbo RJ. Immunocytochemical evaluation of proliferating cell nuclear antigen. Ki-67 (MIB-1), and p53 in predicting survival of primary and metastatic malignant melanomas. Appl. Immunohistochem. 1996: 4; 25-33.
18. McCormick D, Hall PA. The complexities of proliferating cell nuclear antigen. Histopathology 1992; 21; 591-594.
19. Coltrera MD, Skelly M, Gown AM. Anti-PCNA antibody PC10 yields unreliable proliferation indexes in routinely processed, deparaffinized, formalin-fixed tissue. Appl. Immunohistochem. 1993; 1; 193-200.
20. Hall PA, Levison DA, Woods AL et al. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J. Pathol. 1990; 162; 285-294.
21. Ross M, Pezzi C, Pezzi T, Meurer D, Hickey R, Balch C. Patterns of failure in anorectal melanoma. A guide to surgical therapy. Arch. Surg. 1990; 125: 313-316.
22. Longo WE, Vernava AM 3rd, Wade TP, Coplin MA, Virgo KS, Johnson FE. Rare anal canal cancers in the U.S. veteran: patterns of disease and results of treatment. Am. Surg. 1995: 61; 495-500.
23. Cohen D, Siegel B, Jacob E. Anorectal melanomas in Israel. Harefuah 1983; 105; 3-4. 48.
24. Konstadoulakis MM, Ricaniadis N, Walsh D, Karakousis CP. Malignant melanoma of the anorectal region. J. Surg. Oncol. 1995: 58; 118-120.
25. Brady MS, Kavolius JP, Quan SHQ. Anorectal melanoma. A 64-year experience at Memorial Sloan-Kettering Cancer Center. Dis. Colon Rectum 1995: 38; 146-151.
26. Ramsey JA, From L, Iscoe NA, Kahn HJ. MIB-1 proliferative activity is a significant prognostic factor in primary thick cutaneous melanomas. J. Invest. Dermatol. 1995: 105; 22-26.
27. Smolle J, Hofmann-Wellenhof R, Kerl H. Prognostic significance of proliferation and motility in primary malignant melanoma of the skin. J. Cutan. Pathol. 1992; 19; 110-115.
28. Soyer HP. Ki67 immunostaining in melanocytic skin tumors. Correlation with histological parameters. J. Cutan. Pathol. 1991; 18: 264-272.
29. Kaudewitz P, Braun-Falco O, Ernst M, Landthaler M, Stolz W, Gerdes J. Tumor cell growth fractions in human malignant melanomas and the correlation to histopathological tumor grading. Am. J. Pathol. 1989: 134: 1063-1068.
30. Thibault C, Sagar P, Nivatvongs S, Ilstrup DM, Wolff BG. Anorectal melanoma - an incurable disease? Dis. Colon Rectum 1997; 40; 661-668.